Paid Clinical Trials in Katy, TX

As of August 2026, 54 paid clinical trials are recruiting in Katy, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 10, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

52 clinical trials

A Study of RSLV-132 in Females With Sjögren's Disease

for Primary Sjögren Syndrome

Sites in Katy, Richmond +22 more locations

Sponsor: Resolve Therapeutics

Sex: Female·Age: 18 - 75

Code: NCT06440525·Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

Matrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot Ulcers

for Diabetic Foot Ulcer (DFU)

Sites in Katy, Sugar Land +16 more locations

Sponsor: LifeNet Health

Sex: All·Age: 21 - 80

Code: NCT07116876·Recruiting·Listed Aug 2025

Apply to this trial

A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

for Neovascular (Wet) Age-related Macular Degeneration

Sites in Katy +2 more locations

Sponsor: Skyline Therapeutics

Sex: All·Age: 50+

Code: NCT06346600·Recruiting·Listed Apr 2024

Apply to this trial

Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)

for Neovascular Age-related Macular Degeneration

Sites in Katy +3 more locations

Sponsor: Skyline Therapeutics (US) Inc.

Sex: All·Age: 50+

Code: NCT05986864·Phase 1, Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants: a Pilot Study

for Urinary Tract Infection

Sites in Katy, Houston +1 more location

Sponsor: Baylor College of Medicine

Sex: Male·Age: 0 Months - 5 Months

Code: NCT07508124·Phase 4·Recruiting·Listed Apr 2026

Apply to this trial

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

for Type2Diabetes

Sites in Katy, McKinney +34 more locations

Sponsor: Brigham and Women's Hospital

Sex: All·Age: 40 - 80

Code: NCT05390892·Phase 4·Recruiting·Listed May 2022

Apply to this trial

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

for Endometrial Cancer

Sites in Katy, Houston +18 more locations

Sponsor: Mayo Clinic

Sex: Female·Age: 18+

Code: NCT05051722·Recruiting·Listed Sep 2021

Apply to this trial

The Neighborhood & Health Study

for Healthy Eating

Sites in Katy & Richmond

Sponsor: Texas A&M University

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06950775·Recruiting·Listed Apr 2025

Apply to this trial

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

for Pulmonary Disease, Chronic Obstructive

Drug: Depemokimab

Sites in Katy, Stafford +40 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 40 - 75

Code: NCT07177339·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity

for Primary Sjögren's Syndrome

Drug: IMVT-1402

Sites in Katy, Houston +27 more locations

Sponsor: Immunovant Sciences GmbH

Sex: All·Age: 18 - 74

Code: NCT06979531·Phase 2·Recruiting·Listed May 2025

Apply to this trial

A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

for Systemic Lupus Erythematosus

Sites in Katy, Houston +39 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT06411249·Phase 4·Recruiting·Listed May 2024

Apply to this trial